Disease Area: Fibrosis

Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model

Insights Into the Cellular and Molecular Mechanisms Behind the Antifibrotic Effects of Nerandomilast

Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system

LEADS – a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing

Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip

A dynamic microscale mid-throughput fibrosis model to investigate the effects of different ratios of cardiomyocytes and fibroblasts